24-27 giugno
Firenze, Italia
Abstract: 318 – NMS-P088 is a small molecule potent CSF1R kinase inhibitor with macrophages immunomodulatory activity
Home / EACR AACR SIC:The challenges of optimising immuno and targeted therapies – from cancer biology to clinic
24-27 giugno
Firenze, Italia
Abstract: 318 – NMS-P088 is a small molecule potent CSF1R kinase inhibitor with macrophages immunomodulatory activity
Nerviano Medical Sciences S.r.l.
Viale Luigi Pasteur 10
20014 Nerviano (MI)
Italy
Share Capital: € 1,200,000.00
fully paid-in
Company subject to the management and coordination of NMS Group S.p.A.